WALTHAM, Mass., Aug. 31 /PRNewswire/ — Repligen Corporation
(Nasdaq:
RGEN) announced today that the Company President and Chief
Executive Officer, Walter C. Herlihy, Ph.D., will present at the
Rodman & Renshaw Annual Global Investment Conference on Monday,
September 13th, 2010 at 12:05 p.m. EDT at the New York Palace
Hotel, 455 Madison Avenue, New York, NY. A live audio webcast
of the presentation will be available via Repligen’s website at www.repligen.com and will be
archived for 30 days following the presentation.
About Repligen Corporation
Repligen Corporation is a biopharmaceutical company focused on
building an integrated company by developing and marketing
innovative drugs that deliver the benefits of protein therapies in
the fields of neurology and gastroenterology. We have a core
competency in large-scale protein manufacturing and have
out-licensed certain biologics intellectual property, which provide
ongoing sources of revenue. Repligen’s corporate headquarters
are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA
02453. Additional information may be requested from www.repligen.com.
This press release contains forward-looking statements which
are made pursuant to the safe harbor provisions of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical statements, including,
without limitation, statements regarding future financial
performance and position, management’s strategy, plans and
objectives for future operations, plans and objectives for product
development, pl
‘/>”/>
SOURCE
